Procalcitonin: Inflammatory Biomarker for Assessing the Severity of Community-Acquired Pneumonia – A Clinical Observation in Geriatric Patients

Publisher： Karger

E-ISSN： 1423-0003|56|4|385-389

ISSN： 0304-324x

Source： Gerontology, Vol.56, Iss.4, 2009-11, pp. : 385-389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood

By Don Massimiliano   Valent Francesca   Korppi Matti   Falleti Edmondo   De Candia Alessandro   Fasoli Lolita   Tenore Alfred   Canciani Mario  

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 2, 2007-01 ,pp. : 129-137

Informa Healthcare

Access to resources Recommend Favorite

Empiric antimicrobial therapy of community-acquired pneumonia: Clinical diagnosis versus procalcitonin levels

By Cunha Burke  

Scandinavian Journal of Infectious Diseases, Vol. 41, Iss. 10, 2009-01 ,pp. : 782-784

Informa Healthcare

Access to resources Recommend Favorite

Community‐Acquired Pneumonia in Older Patients

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 5, 1996-05 ,pp. : 539-544

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia

By Johansson Niclas   Kalin Mats   Hedlund Jonas  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 8, 2011-08 ,pp. : 609-615

Informa Healthcare

Access to resources Recommend Favorite

Severity of illness assessment in community-acquired pneumonia

By Challen Kirsty   Bentley Andrew   Walter Darren   Bright John  

Intensive Care Medicine, Vol. 34, Iss. 5, 2008-05 ,pp. : 967-967

Springer Publishing Company

Access to resources Recommend Favorite